Log in to save to my catalogue

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia--results of th...

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia--results of th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A572678465

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia--results of the AMLSG 11-08 trial

About this item

Full title

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia--results of the AMLSG 11-08 trial

Publisher

Nature Publishing Group

Journal title

Leukemia, 2018, Vol.32 (7), p.1621

Language

English

Formats

Publication information

Publisher

Nature Publishing Group

More information

Alternative Titles

Full title

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia--results of the AMLSG 11-08 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A572678465

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A572678465

Other Identifiers

ISSN

0887-6924

DOI

10.1038/s41375-018-0129-6

How to access this item